Provided by Tiger Trade Technology Pte. Ltd.

Janux Therapeutics, Inc.

18.22
+0.19001.05%
Post-market: 18.220.00000.00%19:30 EDT
Volume:712.59K
Turnover:12.95M
Market Cap:1.11B
PE:-11.09
High:18.39
Open:17.89
Low:17.66
Close:18.03
52wk High:35.34
52wk Low:12.12
Shares:61.14M
Float Shares:49.82M
Volume Ratio:0.84
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6429
EPS(LYR):-1.8336
ROE:-10.70%
ROA:-8.80%
PB:1.20
PE(LYR):-9.94

Loading ...

Jul 19, 2023

Major Issues Report

Form 8-K - Current report
Jul 17, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 17, 2023

Major Issues Report

Form 8-K - Current report
Jul 10, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 24, 2023

Major Issues Report

Form 8-K - Current report
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
May 31, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 10, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 23, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 22, 2022

Major Issues Report

8-K - Current report
Sep 15, 2022

Correspondence

CORRESP [Cover] - Correspondence